» Articles » PMID: 26925536

Efficacy of Epithelium-Off and Epithelium-On Corneal Collagen Cross-Linking in Pediatric Keratoconus

Overview
Specialty Ophthalmology
Date 2016 Mar 2
PMID 26925536
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To evaluate the efficacy of riboflavin/ultraviolet A epithelium-off (epi-off) and epithelium-on (epi-on) corneal collagen cross-linking (CXL) in progressive pediatric keratoconus.

Methods: Thirty-six eyes of 27 patients aged 18 years or younger (12-18 years) diagnosed with progressive keratoconus and treated with epi-off (n=18 eyes) or epi-on (n=18 eyes) CXL were included in this study. All patients were followed up for 24 months postoperatively.

Results: At 24-month follow-up, the mean corrected distance visual acuity (CDVA) improved from 0.24±0.17 to 0.17±0.11 logMAR in the epi-off group (P=0.032). In the epi-on group, CDVA improved from 0.33±0.23 to 0.26±0.20 logMAR (P=0.012), but the improvement was not significantly different between groups (P>0.05). In the epi-off group, all mean K values improved: K1 (Δ=-0.63 D, P=0.024), K2 (Δ=-0.73 D, P=0.008), and Kmax (Δ=-1.4 D, P=0.035), whereas in the epi-on group, Kmax and K2 did not change significantly and K1 (Δ=0.68 D, P=0.029) significantly worsened. Postoperative mild corneal haze occurred in 5 eyes (28%) in the epi-off group. No postoperative complications were observed in the epi-on group. In 94.4% of the epi-off group, keratoconus regressed (44.4%) or stabilized (50.0%), whereas in the epi-on group, only 66.6% regressed (33.3%) or stabilized (33.3%), and the difference was significant (P=0.038).

Conclusions: The efficacy of the epi-on procedure in terms of its ability to halt keratoconus progression appears to be 0.70 of the efficacy of epi-off CXL.

Citing Articles

Paediatric cornea crosslinking current strategies: A review.

Prasher P, Sharma A, Sharma R, Vig V, Nirankari V Adv Ophthalmol Pract Res. 2023; 3(2):55-62.

PMID: 37846374 PMC: 10577868. DOI: 10.1016/j.aopr.2022.11.002.


Pediatric Crosslinking: Current Protocols and Approach.

Polido J, Dos Xavier Santos Araujo M, Alexander J, Cabral T, Ambrosio Jr R, Freitas D Ophthalmol Ther. 2022; 11(3):983-999.

PMID: 35482230 PMC: 9114245. DOI: 10.1007/s40123-022-00508-9.


Comparison of Efficacy and Safety Between Standard, Accelerated Epithelium-Off and Transepithelial Corneal Collagen Crosslinking in Pediatric Keratoconus: A Meta-Analysis.

Li Y, Lu Y, Du K, Yin Y, Hu T, Fu Y Front Med (Lausanne). 2022; 9:787167.

PMID: 35372437 PMC: 8968048. DOI: 10.3389/fmed.2022.787167.


Analysis of Tear Function Outcomes following Collagen Cross-Linking Treatment in Ectatic Corneas.

Wang X, Bai X, Jin C, Zhao L, Wei R J Ophthalmol. 2022; 2022:1910607.

PMID: 35321348 PMC: 8938138. DOI: 10.1155/2022/1910607.


Corneal collagen cross-linking epithelium-on vs. epithelium-off: a systematic review and meta-analysis.

DOria F, Palazon A, Alio J Eye Vis (Lond). 2021; 8(1):34.

PMID: 34565473 PMC: 8465763. DOI: 10.1186/s40662-021-00256-0.